MedTrace Logo

Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

NCT04526093 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-03-30

No results posted yet for this study

Summary

This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.

Conditions

Interventions

OTHER

Medical Cannabis

Verified medical cannabis products available within the current real-world study conform to Health Canada testing requirements

Sponsors & Collaborators

  • Avicanna Inc

    collaborator INDUSTRY

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Hance Clarke, MD, PhD · Toronto General Hospital, UHN

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-15
Primary Completion
2027-03-31
Completion
2027-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04526093 on ClinicalTrials.gov